Sorting by: date (All)
Date
Rank
Live rank
Popular

News tagged with durvalumab

ESMO: PARP inhibitor plus immunotherapy lowers risk of endometrial cancer progression over chemotherapy alone

Oct 23, 2023

Lung cancer outcomes found to significantly improve with immunotherapy-based treatment given before and after surgery

Oct 23, 2023

Immunotherapy shows promise as a kinder first-line treatment for advanced head and neck cancers

Oct 4, 2023

Understanding surgical outcomes of perioperative durvalumab in AEGEAN study

Sep 11, 2023

Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery

Apr 16, 2023

Researchers find less-invasive treatment for certain head and neck cancers

Nov 28, 2022

Phase II trial shows addition of durvalumab to radiation does not improve outcomes over cetuximab for HNSCC patients

Oct 24, 2022

Association between KRAS/STK11/KEAP1 mutations and outcomes in POSEIDON

Aug 9, 2022

Phase II study of Durvalumab plus concurrent radiotherapy in unresectable locally advanced NSCLC

Aug 8, 2022

Combo immunotherapy ups survival in advanced liver cancer

Jan 24, 2022
Load more